Literature DB >> 26189350

Adenoendocrine cell carcinoma of the extrahepatic bile duct: a case report and review of the literature.

Toshihiko Masui1, Ryuichiro Doi2, Yoshiya Kawaguchi2, Yasuhiro Iwanaga2, Tatsuo Ito2, Masayuki Koizumi2, Shinji Uemoto2.   

Abstract

Extrahepatic bile duct cancer with an endocrine cell component has rarely been reported. We report here on a case of adenoendocrine cell carcinoma in the middle bile duct. An 82-year-old man was admitted to hospital for jaundice and anorexia. Computed tomography and magnetic resonance imaging examination showed a papillary low-density mass in the middle bile duct. Endoscopic retrograde cholangiography showed obstruction of the bile duct, and blushing cytology of the bile duct revealed an adenocarcinoma. We resected the extrahepatic bile duct with regional lymph node dissection. A pathological examination revealed a neuroendocrine component showing small cytoplasmic cells with hyperchromatic nuclei and a rosette-like structure in the middle of the tumor. In the peripheral mucosal region, there was a well-differentiated adenocarcinoma composed of columnar and cuboidal epithelial cells with clear and slightly granular eosinophilic cytoplasm. Immunohistochemical analysis showed positive staining for CD56, following the diagnosis of adenoendocrine cell carcinoma. The Ki-67 rate was >30% suggesting a small-cell endocrine carcinoma. The adenocarcinoma component infiltrated into the endocrine component, and some of the endocrine component was positive for cytokeratin, suggesting transdifferentiation of the adenocarcinoma into the endocrine component rather than originating from the common precursor cell. The patient experienced liver metastasis 3 months after the operation and died 6 months after the operation. Adenoendocrine tumor of the bile duct is extremely rare and adjuvant chemotherapy is necessary according to the malignant potential of the neuroendocrine tumor rather than the adenocarcinoma.

Entities:  

Keywords:  Adenoendocrine tumor; Bile duct cancer

Year:  2011        PMID: 26189350     DOI: 10.1007/s12328-011-0220-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  9 in total

Review 1.  Malignant carcinoid tumor of the common bile duct: report of a case.

Authors:  Dong-Hee Kim; Moon-Hee Song; Dong-Hoon Kim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Small cell neuroendocrine (oat cell) tumour of the common bile duct.

Authors:  A C van der Wal; D J Van Leeuwen; N Walford
Journal:  Histopathology       Date:  1990-04       Impact factor: 5.087

3.  Primary oat cell carcinoma of the common bile duct.

Authors:  S Sabanathan; H Hashimi; G Nicholson; A S Edwards
Journal:  J R Coll Surg Edinb       Date:  1988-10

4.  Carcinoid tumors of the extrahepatic bile duct. A rare cause of malignant biliary obstruction.

Authors:  R S Chamberlain; L H Blumgart
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

5.  Composite tumor (ordinary adenocarcinoma, typical carcinoid, and goblet cell adenocarcinoid) of the gallbladder: a variety of composite tumor.

Authors:  Y Muto; K Okamoto; M Uchimura
Journal:  Am J Gastroenterol       Date:  1984-08       Impact factor: 10.864

6.  Brain metastases from adenoendocrine carcinoma of the common bile duct: a case report.

Authors:  M Tanaka; S Shibui; K Nomura; Y Nakanishi
Journal:  Jpn J Clin Oncol       Date:  1999-05       Impact factor: 3.019

7.  Somatostatin-containing cells in the extrahepatic biliary tract of humans.

Authors:  H Dancygier; U Klein; U Leuschner; K Hübner; M Classen
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682

8.  Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.

Authors:  Jorge Albores-Saavedra; Kristen Batich; Sarah Hossain; Donald E Henson; Arnold M Schwartz
Journal:  Ann Diagn Pathol       Date:  2009-12       Impact factor: 2.090

9.  Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy.

Authors:  R M Levenson; D C Ihde; M J Matthews; M H Cohen; A F Gazdar; P A Bunn; J D Minna
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

  9 in total
  3 in total

1.  A long-term recurrence-free survival of a patient with the mixed adeno-neuroendocrine bile duct carcinoma: A case report and review of the literature.

Authors:  Wataru Izumo; Ryota Higuchi; Takehisa Yazawa; Shuichiro Uemura; Yutaro Matsunaga; Masahiro Shiihara; Toru Furukawa; Masakazu Yamamoto
Journal:  Int J Surg Case Rep       Date:  2017-08-04

Review 2.  Neuroendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review.

Authors:  Liang Zhang; DaLong Wan; Li Bao; Qing Chen; HaiYang Xie; ShiGuo Xu; ShengZhang Lin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  Mixed adenoendocrine carcinoma in the extrahepatic biliary tract: A case report and literature review.

Authors:  Liang Zhang; Zhengtao Yang; Qing Chen; Mengxia Li; Xiaolu Zhu; Dalong Wan; Haiyang Xie; Shusen Zheng
Journal:  Oncol Lett       Date:  2019-06-20       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.